Comparative Pharmacology
Head-to-head clinical analysis: PSEUDO 12 versus SUDAFED 24 HOUR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PSEUDO 12 versus SUDAFED 24 HOUR.
PSEUDO-12 vs SUDAFED 24 HOUR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Decongestant; acts on alpha-adrenergic receptors in the nasal mucosa to produce vasoconstriction, reducing edema and nasal congestion.
Pseudoephedrine is a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction and reducing nasal congestion.
60 mg orally every 4 to 6 hours as needed; maximum 240 mg per day.
120 mg orally every 24 hours (extended-release tablet).
None Documented
None Documented
Terminal elimination half-life: 4-6 hours (adults); 6-8 hours (children); prolonged in renal impairment (up to 20 hours in severe disease).
Terminal elimination half-life 9-16 hours (mean 11 hours) in adults; prolonged in renal impairment (up to 24-30 hours in severe insufficiency); clinically relevant for dosing interval (every 24 hours)
Renal: 70-90% as unchanged drug; biliary/fecal: <10%
Renal 70-90% unchanged; minor hepatic metabolism to inactive metabolites; biliary/fecal excretion negligible (<5%)
Category C
Category C
Decongestant
Decongestant